top of page
Executive Spotlights

Mr. Chris White has been appointed as New President and Chief Financial Officer of Strams Biotech

Houston, TX, August 29, 2023 (PRNewswire) -- The Chief Executive Officer of Houston-based Biotechnology Company Stramsen Biotech Inc. Dr. Kefas Mugittu (Ph.D.) has announced 32 Drug candidates in company's pipeline at a company's board meeting. These are new natural plant-based medicine candidates that are in different stages. The company's Board Members' meeting took place on July 30, 2023.

Read full article here.

Recent Posts

See All


Life Science Headlines
bottom of page